News
News stories and community announcements concerning members of the Department of Epidemiology and Population Health, as well as interviews.
EPH PhD Students Research Climate Change and Cardiovascular Health
EPH Professor Julie Parsonnet explains how doctors can make gun safety part of routine care
“There are specific at-risk groups that we know are at high risk of gun violence or gun injury,” says Parsonnet. “Safe storage reduces those deaths and, just like having a car seat, we should be talking to families about it.”
EPH Assistant Professor Lisa Goldman Rosas' Food for Health Equity Lab working with Instacart on White House health initiative
Epidemiology and Population Science Featured in the Latest Issue of Stanford Medicine Magazine
Feb. 1, 2023 - The year's first issue of Stanford Medicine Magazine focuses on the nonmedical factors that impact health. This issue heavily features the work and research of Epidemiology and Population Health faculty.
In the magazine's feature section:
- David Rehkopf explains social determinants of health;
- Abby King describes the Our Voice citizen science method designed to help community members track facilitators and barriers to healthy living in their own neighborhoods; and
- Stanford Center for Population Health Sciences is recognized for providing access to large databases that can be used to address population health questions.
Elsewhere in the magazine:
- Alyce Adams explains her work to improve the quality of health care and outcomes for minoritized individuals and those from underserved communities; and
- An article focused on David Rehkopf's mission to understand the secret to longevity in Nicoya, Costa Rica.
Dr. Abby King Appointed to Susan and David Heckerman Professorship
October 27, 2022. The Department of Epidemiology and Population Health is pleased to share the news that Abby King, Professor of Epidemiology and Population Health and of Research, is the newest holder of the Susan and David Heckerman Professorship. The professorship was made possible by gifts from Susan and David Heckerman, PhD ’90, MD ’92.
Dr. King’s research focuses on the development, evaluation and translation of public health interventions to reduce chronic disease in the US and globally. Her current research focuses on expanding the reach and generalizability of evidence-based interventions through use of state-of-the-art communication technologies; community-based participatory research perspectives to address health disparities among disadvantaged populations; and policy-level approaches to health promotion. Dr. King and Dr. Heckerman share a strong interest in improving health by addressing diet and exercise across diverse groups.
Dr. King’s professorship was confirmed by the Stanford Board of Trustees in October 2022.
Lorene Nelson & Stanford colleagues win UCB-Stanford Industrial Relation & Digital Health Research Award
February 14, 2022. Ying Lu, together with visiting scholar Ruben van Eijk and Tze Lai and Lu Tian of the Department of Biomedical Data Science and the Center for Innovative Study Design, plus Lorene Nelson of Epidemiology and the Center for Population Health Sciences [pictured here], have recently won an award from UC Berkeley-Stanford Industrial Relations & Digital Health Research Project Solicitations on their proposed project, "Integrating Real World Evidence from Concurrent Registries into ALS Clinical Trials." This award paves the way for software development and training for industry users.
Read more about the UCB and Stanford Digital Health Research Collaborative
Stanford pediatric arbovirologist Desiree LaBeaud’s quest to eradicate mosquito-borne diseases led to an unlikely culprit: plastic trash
February 9, 2022. "In 2021, Stanford pediatrician and arbovirologist Desiree LaBeaud and her colleagues launched the nonprofit organization HERI-Kenya to reduce the spread of mosquito-borne diseases in Kenya by cleaning up the plastic waste where the insects breed."
Patricia Rodriguez Epinosa's work with Promotoras de Salud Community of Practice recognized by Community Partnership Award
January 31, 2022. "Promotoras de Salud Community of Practice," a partnership developed by E&PH faculty researcher Patricia Rodriguez Espinosa from the ground up as part of the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities study, has been selected for a Community Partnership Award. This achievement will be recognized at the Community Partnership Awards and Roland Prize Luncheon on March 4, 2022.
Abby C. King Awarded Miriam Aaron Roland Volunteer Service Prize
January 31, 2022. Dr. Abby C. King, Professor and Vice Chair for Academic Affairs in the Department of Epidemiology and Population Health; Professor of Medicine, has been awarded the Miriam Aaron Roland Volunteer Service Prize. She is being celebrated for her commitment to health equity, access, and outcomes. Dr King will be honored at the Community Partnership Awards and Roland Prize Luncheon on March 4th.
Lisa Goldman Rosas receives SBM's Award for Health Engagement
January 13, 2022. Warm congratulations to Lisa Goldman Rosas for being honored with the Society of Behavioral Medicine's (SBM's) Jessie Gruman Award For Health Engagement! It is a tremendous achievement to be chosen for this prestigious national award, which recognizes outstanding work in, and commitment to, patient engagement and health equity.
Jade Benjamin-Chung named Chan Zuckerberg Biohub Investigator
January 11, 2022. E&PH faculty researcher Jade Benjamin-Chung had been selected to join the second cohort of scientists to be named Chan Zuckerberg Biohub Investigators following a competition for individual awards. (The first competition for individual awards was held in 2016, for awards beginning 2017, and a competition for team-based awards was held in 2018.) The Chan Zuckerberg Biohub Investigator Program, open to faculty from Stanford University, UC San Francisco, and UC Berkeley, funds innovative, visionary research with the goal of building and sustaining an engaged, interactive, and collaborative community of researchers that spans across disciplines and across the three campuses to help solve critical challenges in biomedicine.
Column: The Theranos verdict won’t stop investors from pouring money into the next big fraud
January 3, 2022. E&PH faculty researcher John Ioannidis is featured in this column. To Dr. Ioannidis, Theranos's choice to develop its tech secretly presented a risk: “Stealth research creates total ambiguity about what evidence can be trusted in a mix of possibly brilliant ideas, aggressive corporate announcements, & mass media hype.”
